New drug aims to restart periods in women with exercise-related amenorrhea
NCT ID NCT07235917
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study tests an experimental drug called mibavademab in 34 women with Functional Hypothalamic Amenorrhea (FHA), a condition where periods stop due to stress or intense exercise. The goal is to see if the drug can help the body produce the hormones needed for ovulation and improve bone health. Participants will receive either the drug or a placebo, and researchers will monitor hormone levels and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL HYPOTHALAMIC AMENORRHEA (FHA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arensia Exploratory Medicine Clinic
RECRUITINGPhoenix, Arizona, 85015, United States
-
Focus Clinical Research
RECRUITINGWest Hills, California, 91307, United States
-
Mayo Clinic Florida
RECRUITINGJacksonville, Florida, 32224, United States
-
OBGYN Associates of Erie
RECRUITINGErie, Pennsylvania, 16507, United States
-
Oregon Health and Science University (OHSU)
RECRUITINGPortland, Oregon, 97239, United States
-
Penn State Health Milton South Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033, United States
-
Tidewater Clinical Research - Tidewater Physicians for Women
RECRUITINGNorfolk, Virginia, 23502, United States
-
University of Virginia School of Medicine
RECRUITINGCharlottesville, Virginia, 22908, United States
-
Yale University School of Medicine
RECRUITINGNew Haven, Connecticut, 06510, United States
-
Zillan Clinical Research
RECRUITINGHouston, Texas, 77082, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.